Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3034

Actual shortage: 241 (8%)
Anticipated shortage: 18 (1%)
Avoided shortage: 9 (0%)
Resolved: 2766 (91%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

30 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MIRVALA 28 0.0300MG 0.1500MG TABLET Resolved 2022-01-14 2022-01-18 152779
APO-SIMVASTATIN 80MG TABLET Resolved 2022-01-14 2022-04-18 152776
APO-SAXAGLIPTIN 2.5MG TABLET Resolved 2022-01-14 2022-07-19 152773
APO-NAPROXEN EC 375MG TABLET (ENTERIC-COATED) Resolved 2022-01-14 2022-02-07 152770
APO-DESVENLAFAXINE 100MG TABLET (EXTENDED-RELEASE) Resolved 2022-01-14 2022-02-18 152764
APO-DESVENLAFAXINE 100MG TABLET (EXTENDED-RELEASE) Resolved 2022-01-14 2022-02-18 152761
APO-DARIFENACIN 15MG TABLET (EXTENDED-RELEASE) Resolved 2022-01-14 2022-02-03 152758
APO-QUINAPRIL/HCTZ 25MG 20MG TABLET Actual shortage 2022-01-07 2022-05-06 152332
OVIMA 28 30MCG 150MCG TABLET Resolved 2022-01-07 2022-02-07 152329
APO-OLMESARTAN 20MG TABLET Resolved 2022-01-07 2022-02-07 152324
APO-MIDODRINE 2.5MG TABLET Resolved 2022-01-07 2022-04-22 152313
APO-GABAPENTIN 300MG CAPSULE Resolved 2022-01-07 2022-01-31 152310
APO-DIVALPROEX 250MG TABLET (DELAYED-RELEASE) TABLET (ENTERIC-COATED) Resolved 2022-01-07 2022-02-04 152307
APO-DICLO 50MG TABLET (ENTERIC-COATED) Resolved 2022-01-07 2022-02-18 152304
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Resolved 2022-01-07 2022-01-24 152301
APO-AZITHROMYCIN Z 250MG TABLET Resolved 2022-01-07 2022-03-21 152298
APO-ATOMOXETINE 10MG CAPSULE Resolved 2022-01-07 2022-03-28 152295
APO-SALBUTAMOL HFA 100MCG METERED-DOSE AEROSOL Resolved 2021-12-24 2021-12-31 151892
APO-OXYCODONE CR 10MG TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE) Resolved 2021-12-24 2022-03-21 151889
APO-DOXYLAMINE/B6 10MG 10MG TABLET (DELAYED-RELEASE) Resolved 2021-12-24 2022-04-14 151886

Showing 1041 to 1060 of 3034

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-CARVEDILOL 25MG TABLET Discontinued 2024-01-26 2024-01-27 217504
APO-CARVEDILOL 6.25MG TABLET To be discontinued 2024-01-26 2024-01-26 217499
APO-CARVEDILOL 3.125MG TABLET To be discontinued 2024-01-26 2024-01-26 217496
APO-CARVEDILOL 12.5MG TABLET To be discontinued 2024-01-26 2024-04-01 217493
APO-VALPROIC ACID ORAL SOLUTION 250MG SOLUTION Discontinued 2023-09-26 2023-11-02 205310
APO-ABACAVIR-LAMIVUDINE-ZIDOVUDINE 300MG 150MG 300MG TABLET Discontinued 2022-12-12 2022-12-12 177953
APO-CLOBETASOL SPRAY 0.05% SPRAY Discontinued 2022-09-06 2022-09-06 168648
APO-BICALUTAMIDE 50MG TABLET Discontinued 2022-03-25 2022-05-13 157376
MELPHALAN FOR INJECTION 10ML 50MG POWDER FOR SOLUTION KIT SOLUTION Discontinued 2022-03-23 2022-03-23 157136
APO-PINDOL TAB 15MG 15MG TABLET Discontinued 2022-02-09 2022-12-09 154574
APO-PINDOL TAB 10MG 10MG TABLET Discontinued 2022-02-09 2022-02-10 154571
APO-PINDOL TAB 5MG 5MG TABLET Discontinued 2022-02-09 2022-02-10 154568
APO-QUETIAPINE 25MG TABLET Discontinued 2021-06-25 2021-06-25 141546
APO-BRIMONIDINE 0.2% SOLUTION Discontinued 2020-11-16 2020-11-16 128438
APO-QUETIAPINE 25MG TABLET Discontinued 2020-07-10 2020-07-10 119950
APO-AMOXI SUGAR FREE 250MG POWDER FOR SUSPENSION Discontinued 2020-06-22 2020-06-22 118526
APO-HYDROMORPHONE CR 9MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110977
APO-HYDROMORPHONE CR 4.5MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110974
APO-HYDROMORPHONE CR 30MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110971
APO-HYDROMORPHONE CR 24MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110968

Showing 1 to 20 of 356